Schwab Charles Investment Management Inc. Buys 9,039 Shares of The Advisory Board Company (NASDAQ:ABCO)

Schwab Charles Investment Management Inc. increased its position in shares of The Advisory Board Company (NASDAQ:ABCO) by 5.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 174,408 shares of the business services provider’s stock after buying an additional 9,039 shares during the period. Schwab Charles Investment Management Inc. owned 0.43% of The Advisory Board worth $8,163,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of ABCO. Howard Hughes Medical Institute bought a new position in shares of The Advisory Board during the first quarter worth about $158,000. American International Group Inc. boosted its position in shares of The Advisory Board by 5.4% in the first quarter. American International Group Inc. now owns 24,841 shares of the business services provider’s stock worth $1,163,000 after buying an additional 1,281 shares during the last quarter. Victory Capital Management Inc. bought a new position in shares of The Advisory Board during the first quarter worth about $109,000. Teachers Advisors LLC boosted its position in The Advisory Board by 4.7% in the fourth quarter. Teachers Advisors LLC now owns 72,192 shares of the business services provider’s stock worth $2,400,000 after buying an additional 3,219 shares in the last quarter. Finally, Corsair Capital Management L.P. acquired a new position in The Advisory Board during the first quarter worth about $2,783,000.

The Advisory Board Company (NASDAQ ABCO) opened at 52.05 on Wednesday. The company has a 50 day moving average price of $54.47 and a 200 day moving average price of $49.35. The firm has a market capitalization of $2.11 billion, a price-to-earnings ratio of 21.09 and a beta of 1.33. The Advisory Board Company has a 12 month low of $24.85 and a 12 month high of $59.50.

The Advisory Board (NASDAQ:ABCO) last announced its quarterly earnings data on Tuesday, August 8th. The business services provider reported $0.24 EPS for the quarter, missing the Zacks’ consensus estimate of $0.32 by $0.08. The Advisory Board had a net margin of 12.78% and a return on equity of 14.48%. The firm had revenue of $200.30 million during the quarter, compared to analyst estimates of $196.16 million. During the same period last year, the business posted $0.46 EPS. The company’s revenue was up 1.0% on a year-over-year basis. Analysts anticipate that The Advisory Board Company will post $1.95 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece of content was posted by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://stocknewstimes.com/2017/08/09/the-advisory-board-company-nasdaqabco-shares-bought-by-schwab-charles-investment-management-inc-updated.html.

A number of research analysts recently issued reports on ABCO shares. Zacks Investment Research cut The Advisory Board from a “buy” rating to a “hold” rating in a report on Tuesday, April 25th. Stifel Nicolaus reiterated a “hold” rating and issued a $53.00 price objective (up from $48.00) on shares of The Advisory Board in a research report on Thursday, July 6th. TheStreet lowered The Advisory Board from a “b-” rating to a “c” rating in a research report on Friday, May 5th. BidaskClub lowered The Advisory Board from a “hold” rating to a “sell” rating in a research report on Saturday. Finally, Credit Suisse Group boosted their target price on The Advisory Board from $54.00 to $55.00 and gave the stock an “outperform” rating in a research report on Monday, May 15th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $50.33.

The Advisory Board Company Profile

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research, Technology, Data-enabled services and Consulting services.

Institutional Ownership by Quarter for The Advisory Board (NASDAQ:ABCO)

Receive News & Ratings for The Advisory Board Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply